Skip to main content

R. Blair McNeill III

Current Position: VP, Head of CMC Biologics and Gene Therapy at Sumitovant Biopharma, Inc., North Carolina


Blair was the pioneer graduate student in the Colbran lab from 1993-98. ┬áHe received his Ph.D. in 1998 with a dissertation entitled: “Characterization of binding proteins for Ca2+/calmodulin-dependent protein kinase II in postsynaptic density”.